These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9177842)

  • 1. Biodistribution and catabolism of Ga-67-labeled anti-Tac dsFv fragment.
    Wu C; Jagoda E; Brechbiel M; Webber KO; Pastan I; Gansow O; Eckelman WC
    Bioconjug Chem; 1997; 8(3):365-9. PubMed ID: 9177842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-lysine effectively blocks renal uptake of 125I- or 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment.
    Kobayashi H; Yoo TM; Kim IS; Kim MK; Le N; Webber KO; Pastan I; Paik CH; Eckelman WC; Carrasquillo JA
    Cancer Res; 1996 Aug; 56(16):3788-95. PubMed ID: 8706025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts.
    Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I
    Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H; Yoo TM; Drumm D; Kim MK; Sun BF; Le N; Webber KO; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1997 May; 57(10):1955-61. PubMed ID: 9157991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminosyn II effectively blocks renal uptake of 18F-labeled anti-tac disulfide-stabilized Fv.
    Carrasquillo JA; Lang L; Whatley M; Herscovitch P; Wang QC; Pastan I; Eckelman WC
    Cancer Res; 1998 Jun; 58(12):2612-7. PubMed ID: 9635587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and specific uptake of anti-Tac disulfide-stabilized Fv by interleukin-2 receptor-bearing tumors.
    Webber KO; Kreitman RJ; Pastan I
    Cancer Res; 1995 Jan; 55(2):318-23. PubMed ID: 7812965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification to reduce renal uptake of disulfide-bonded variable region fragment of anti-Tac monoclonal antibody labeled with 99mTc.
    Kim IS; Yoo TM; Kobayashi H; Kim MK; Le N; Wang QC; Pastan I; Carrasquillo JA; Paik CH
    Bioconjug Chem; 1999; 10(3):447-53. PubMed ID: 10346877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
    Kobayashi H; Sun BF; Yoo TM; Le N; Kim MK; Paik CH; Pastan I; Waldmann TA; Carrasquillo JA
    J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points.
    Kobayashi H; Le N; Kim IS; Kim MK; Pie JE; Drumm D; Paik DS; Waldmann TA; Paik CH; Carrasquillo JA
    Cancer Res; 1999 Jan; 59(2):422-30. PubMed ID: 9927057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
    Uehara T; Rokugawa T; Kinoshita M; Nemoto S; Fransisco Lazaro GG; Hanaoka H; Arano Y
    Bioconjug Chem; 2014 Nov; 25(11):2038-45. PubMed ID: 25303645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope blocking: positive and negative effects on the biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment of two antibodies against different epitopes of the circulating antigen.
    Kobayashi H; Sun BF; Han ES; Kim MK; Le N; Wang QC; Nelson DL; Pastan I; Waldmann TA; Paik CH; Carrasquillo JA
    Jpn J Cancer Res; 1998 Apr; 89(4):436-44. PubMed ID: 9617350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities in the biodistribution of iodine-labeled anti-Tac single-chain disulfide-stabilized Fv fragment and anti-Tac disulfide-stabilized Fv fragment.
    Kobayashi H; Han ES; Kim IS; Le N; Rajagopal V; Kreitman RJ; Pastan I; Paik CH; Carrasquillo JA
    Nucl Med Biol; 1998 May; 25(4):387-93. PubMed ID: 9639301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the in vivo pharmacokinetics of peptides and antibody fragments: the pharmacokinetics of two PET-labeled low molecular weight proteins.
    Lang L; Jagoda E; Wu C; Brechbiel MW; Gansow OA; Pastan I; Paik CH; Carrasquillo JA; Eckelman WC
    Q J Nucl Med; 1997 Jun; 41(2):53-61. PubMed ID: 9203844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin.
    Kobayashi H; Kao CH; Kreitman RJ; Le N; Kim MK; Brechbiel MW; Paik CH; Pastan I; Carrasquillo JA
    J Nucl Med; 2000 Apr; 41(4):755-62. PubMed ID: 10768579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m labeling and biodistribution of anti-TAC disulfide-stabilized Fv fragment.
    Yoo TM; Chang HK; Choi CW; Webber KO; Le N; Kim IS; Eckelman WC; Pastan I; Carrasquillo JA; Paik CH
    J Nucl Med; 1997 Feb; 38(2):294-300. PubMed ID: 9025758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
    Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
    Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.